These results suggest that TGF-β1-induced MEK-ERK1/2 signaling is involved post-transcriptionally in the suppression of PTEN protein, whereas it is not involved in the down-regulation of PTEN mRNA in type II endometrial cancer cells. This evidence concerns the gene MAPK3 and endometrial cancer.